Stock Report

Download full stock data and analysis for free Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$79.89

up-down-arrow $0.61 (0.77%)

As on 02-Sep-2026 16:00EDT

Market cap

info icon

$6,092 Mln

Revenue (TTM)

info icon

$841 Mln

P/E Ratio

info icon

78.9

P/B Ratio

info icon

9.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 13.69 55.36 58.85 44.13 155.62
EBIT -16.79 18.87 673.39 36.92 21.00
Net Profit 12.57 42.62 1,583.88 -29.61 19.41
EPS 11.24 33.29 2,323.43 -32.75 18.71
Book Value -- -- 18.54 8.99 9.41
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -0.53-80.5913.1213.12-8.54
Net Margin info ---162.949.59----
Return on equity info 1.750.9613.2011.73-9.85
Return on Capital info 1.741.02--11.51-9.60
Return on Assets info 1.280.518.748.78-7.80
Debt to Equity (x) info ----0.000.020.02

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
11.51
-9.60
3.30
61.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

13.20

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
13.20
11.73
-9.85
3.37
63.10
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

8.74

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
8.74
8.78
-7.80
2.86
52.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

13.12

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
13.12
13.12
-8.54
-6.16
5.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

9.59

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
9.59
8.71
-10.21
5.21
82.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

58.85

--

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
58.85
0.60
0.57
0.23
4.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

673.39

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
673.39
345.82
-117.10
-251.02
107.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

1,583.88

--

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
1,583.88
236.61
-406.68
-92.32
216.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

2,323.43

--

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
2,323.43
2.25
-4.08
-0.92
2.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

23.50

--

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
23.50
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
0.02
0.02
0.03
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
0.01
0.01
0.00
0.01
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.90

--

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
3.90
3.79
3.30
4.34
5.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.49

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
3.49
3.39
3.04
3.85
4.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
--
--
--
8.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

2.79

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
2.79
2.30
9.86
7.87
9.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.91

--

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
0.91
1.01
0.76
0.55
0.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
15.45
27.18
28.10
20.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
48.27
172.36
170.34
201.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
2.42
30.84
52.16
77.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
61.31
168.70
146.27
143.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

78.87

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
78.87
55.21
-33.12
90.49
5.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

9.51

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
9.51
5.74
3.26
2.90
2.70
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

55.91

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
55.91
31.56
-34.73
-75.49
65.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

6,092

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
6,092
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...